^
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Esophageal Cancer
ALK positive
NSCLC
MSI-H/dMMR
CRC
PD-L1 expression
Triple Negative Breast Cancer
No biomarker
Triple Negative Breast Cancer
No biomarker
Sarcoma
No biomarker
Small Cell Lung Cancer
No biomarker
Endometrial Cancer
No biomarker
Triple Negative Breast Cancer
FGFR2 rearrangement
Cholangiocarcinoma
FGFR2 fusion
Cholangiocarcinoma
HER-2 negative
HER2 Negative Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
EGFR mutation
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
PTEN deletion
Prostate Cancer
EGFR overexpression
HCC
GATA6 underexpression
Pancreatic Ductal Adenocarcinoma
BRAF V600
LUAD
No biomarker
Lung Non-Small Cell Squamous Cancer
EGFR mutation
NSCLC
EGFR exon 19 mutation
NSCLC
EGFR exon 21 mutation
NSCLC
EGFR mutation
NSCLC
EGFR mutation
NSCLC
ER positive
HER2 Positive Breast Cancer
PD-L1 expression
NSCLC
EGFR exon 19 deletion
NSCLC
ROS1 mutation
NSCLC
HER-2 mutation
NSCLC
ALK mutation
NSCLC
EGFR exon 21 mutation
NSCLC
EGFR L858R
NSCLC
ROS1 positive
NSCLC
EGFR G2607A
Lung Cancer
KRAS G12V
CRC
KRAS G12D
CRC
EGFR exon 18-25 duplication
NSCLC
KRAS mutation + ATM mutation
Rectal Cancer
ER Y537S
Estrogen Receptor Positive Breast Cancer
JARID2 overexpression
Glioma
TUSC7 overexpression
Triple Negative Breast Cancer
TUSC7 overexpression
Triple Negative Breast Cancer
BRAF V600E
Thyroid Gland Papillary Carcinoma
MTA2 expression
Gastric Cancer
No biomarker
Prostate Cancer
PD-L1 overexpression
NSCLC
PTEN deletion
Prostate Cancer
HER-2 amplification
Breast Cancer
PDGFRA D842V
GIST
HER-2 positive
Gastric Cancer
PD-L1 overexpression
NSCLC
MSI-H/dMMR
CRC
HER-2 positive
Gastric Cancer
BRAF V600E
CRC
BRAF V600E
CRC
HER-2 overexpression
Breast Cancer
HRD
Prostate Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
NRAS mutation
CRC
NTRK3 fusion
Pancreatic Cancer
NTRK2 fusion
Pancreatic Cancer
NTRK1 fusion
Pancreatic Cancer
NTRK3 fusion
Esophageal Cancer
NTRK2 fusion
Esophageal Cancer
NTRK1 fusion
Esophageal Cancer
NTRK3 fusion
HCC
NTRK2 fusion
HCC
NTRK1 fusion
HCC
BRAF mutation
CRC
KRAS mutation
CRC
BRCA2 mutation
HER2 Negative Breast Cancer
BRCA1 mutation
HER2 Negative Breast Cancer
SSTR positive
Neuroendocrine Tumor
MSI-H/dMMR
Solid Tumor
NTRK3 fusion
Cholangiocarcinoma
NTRK2 fusion
Cholangiocarcinoma
NTRK1 fusion
Cholangiocarcinoma
KRAS exon 2 mutation
CRC
PD-L1 expression
Esophageal Cancer
POLE mutation
Solid Tumor
FGFR2 mutation
Cholangiocarcinoma
KRAS mutation
Pancreatic Ductal Adenocarcinoma
MSI-H/dMMR + KRAS Mutation
CRC
MSI-H/dMMR + BRAF Mutation
CRC
BRAF mutation
Mucosal Melanoma
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 positive
Gastric Cancer
KIT mutation
Mucosal Melanoma
NRAS mutation
Cutaneous Melanoma
BRAF mutation
Cutaneous Melanoma
PIK3CA mutation
CRC
HER-2 mutation
NSCLC
NRAS mutation
Mucosal Melanoma
ANGPT2-H
CRC
KIT mutation
Cutaneous Melanoma
KRAS G12C
CRC
MSI-H/dMMR
Gastrointestinal Cancer
MSI-H/dMMR + NTRK3 fusion
CRC
MSI-H/dMMR + NTRK2 fusion
CRC
MSI-H/dMMR + NTRK1 fusion
CRC
PD-L1 expression
Pancreatic Ductal Adenocarcinoma
ANXA6 underexpression
Triple Negative Breast Cancer
EGFR expression
Triple Negative Breast Cancer
STRN-ALK fusion + EML4-ALK fusion + EGFR T790M
LUAD
BRAF V600E + TERT mutation
GBM
EGFR exon 18-25 duplication
NSCLC
PIK3CA mutation
CRC
KRAS mutation
CRC
CCL5 overexpression
GBM
MTOR L1433S + EGFR L858R + T790M
NSCLC
EGFR exon 19 deletion
NSCLC
EGFR exon 19 deletion
NSCLC
No biomarker
NSCLC
EGFR exon 19 deletion
NSCLC
PD-L1 expression
Triple Negative Breast Cancer
EGFR L858R
NSCLC
EGFR T790M
NSCLC
No biomarker
NSCLC
ALK positive
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
KIT positive
GIST
HER-2 positive
HER2 Positive Breast Cancer
No biomarker
RCC
No biomarker
Malignant Pleural Mesothelioma
PD-L1 expression
NSCLC
ALK fusion
NSCLC
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
No biomarker
Esophageal Squamous Cell Carcinoma
No biomarker
Fallopian Tube Cancer
No biomarker
Ovarian Cancer
No biomarker
Peritoneal Cancer
KRAS G12C
NSCLC
PD-L1 expression
NSCLC
EGFR L858R
NSCLC
No biomarker
Esophageal Adenocarcinoma
ALK positive
NSCLC
ROS1 fusion
NSCLC
No biomarker
Gastric Cancer
HER-2 positive
HER2 Positive Breast Cancer
MET exon 14 mutation
NSCLC
No biomarker
NSCLC
No biomarker
NSCLC
EGFR L858R
NSCLC
EGFR T790M
NSCLC
EGFR exon 19 deletion
NSCLC
MET exon 14 mutation
NSCLC
PD-L1 overexpression
NSCLC
RET fusion
NSCLC
No biomarker
SCCHN
No biomarker
Gastric Adenocarcinoma
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
NSCLC
No biomarker
Breast Cancer
No biomarker
BCC
PD-L1 expression
Urothelial Cancer
EGFR mutation
NSCLC
EGFR L858R
NSCLC
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Thyroid Gland Medullary Carcinoma
ALK positive
NSCLC
No biomarker
NSCLC
ROS1 positive
NSCLC
RET fusion
NSCLC
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Small Cell Lung Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
BRCA2 mutation
Pancreatic Cancer
PD-L1 expression
NSCLC
EGFR mutation
NSCLC
No biomarker
HCC
No biomarker
HCC
BRCA1 mutation
Pancreatic Cancer
HER-2 positive
HER2 Positive Breast Cancer
RET fusion
Thyroid Gland Carcinoma
FGFR2 rearrangement
Cholangiocarcinoma
No biomarker
NSCLC
No biomarker
Prostate Cancer
FGFR2 fusion
Cholangiocarcinoma
No biomarker
SCCHN
No biomarker
NSCLC
No biomarker
Gastric Cancer
No biomarker
Urothelial Cancer
BRCA1 mutation
Peritoneal Cancer
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
SCCHN
HER-2 positive
HER2 Positive Breast Cancer
MET exon 14 mutation
NSCLC
BRAF V600
Melanoma
No biomarker
Soft Tissue Sarcoma
No biomarker
Colon Cancer
No biomarker
Rectal Cancer
No biomarker
Breast Cancer
HR positive
HER2 Positive Breast Cancer
No biomarker
Urothelial Cancer
No biomarker
Colon Cancer
PD-L1 expression
SCCHN
HR positive
HER2 Negative Breast Cancer
RET mutation
Thyroid Gland Medullary Carcinoma
PD-L1 expression
Esophageal Squamous Cell Carcinoma
PD-L1 expression
RCC
No biomarker
Adrenal Cortex Carcinoma